Olivier Rixe
Impact in
- Pulmonary and Respiratory Medicine top 0.1%
- Renal cell carcinoma treatment
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
Papers in
- Oncology 92
- Cancer Treatment and Pharmacology 22
- Colorectal Cancer Treatments and Studies 12
- Cancer Immunotherapy and Biomarkers 12
- HER2/EGFR in Cancer Research 11
-
- Renal cell carcinoma treatment 32
- Lung Cancer Treatments and Mutations 18
- Co-authors
- Stéphane Oudard (14 shared papers)Robert J. Motzer (9 shared papers)M. Dror Michaelson (6 shared papers)Ronald M. Bukowski (6 shared papers)Paul Bycott (7 shared papers)Thomas E. Hutson (4 shared papers)Piotr Tomczak (4 shared papers)Robert A. Figlin (4 shared papers)
- Journals
- Journal of Clinical Oncology (55 papers)Annals of Oncology (11 papers)European Journal of Cancer (9 papers)Targeted Oncology (9 papers)Cancer Chemotherapy and Pharmacology (7 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Olivier Rixe
198 papers receiving 11.5k citations
Olivier Rixe's Hit Papers
Peers
Comparison fields: 5 of 142
- Pulmonary and Respiratory Medicine 4.9k
- Oncology 3.9k
- Cancer Research 2.0k
- Biological Psychiatry 187
- Molecular Biology 4.1k
Countries citing papers authored by Olivier Rixe
This map shows the geographic impact of Olivier Rixe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Rixe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Rixe more than expected).
Fields of papers citing papers by Olivier Rixe
This network shows the impact of papers produced by Olivier Rixe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Rixe. The network helps show where Olivier Rixe may publish in the future.
Co-authors
The 25 scholars most cited alongside Olivier Rixe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 208 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma Hit paper breakdown → | 2007 | 4636 |
| 2 | Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel Hit paper breakdown → | 1996 | 529 |
| 3 | 2007 | 365 | |
| 4 | 2007 | 354 | |
| 5 | 2008 | 206 | |
| 6 | 2003 | 192 | |
| 7 | 2008 | 188 | |
| 8 | 2006 | 184 | |
| 9 | 2005 | 180 | |
| 10 | 2010 | 176 | |
| 11 | 2005 | 162 | |
| 12 | 2011 | 156 | |
| 13 | 2007 | 150 | |
| 14 | 2018 | 143 | |
| 15 | 2002 | 133 | |
| 16 | 2014 | 129 | |
| 17 | 1993 | 123 | |
| 18 | 2005 | 121 | |
| 19 | 2010 | 119 | |
| 20 | 2013 | 118 |
About Olivier Rixe
Olivier Rixe is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 208 papers that have together received 11.9k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (32 papers), Cancer Treatment and Pharmacology (22 papers), Lung Cancer Treatments and Mutations (18 papers), Cancer Genomics and Diagnostics (17 papers), Tryptophan and brain disorders (13 papers), Colorectal Cancer Treatments and Studies (12 papers), Cancer Immunotherapy and Biomarkers (12 papers) and HER2/EGFR in Cancer Research (11 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.9k citations), Oncology (3.9k citations), Cancer Research (2.0k citations), Biological Psychiatry (187 citations) and Molecular Biology (4.1k citations). Olivier Rixe has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Stéphane Oudard, Robert J. Motzer, M. Dror Michaelson, Ronald M. Bukowski, Paul Bycott, Thomas E. Hutson, Piotr Tomczak, Robert A. Figlin, Charles M. Baum and Isan Chen. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Targeted Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.